Futoshi Kuribayashi Selected Research

Futoshi Kuribayashi Research Topics

Disease

6	Neoplasms (Cancer) 01/2024 - 01/2019
4	Infections 04/2023 - 03/2011
3	Neoplasm Metastasis (Metastasis) 12/2022 - 09/2022
3	Leukemia 11/2020 - 04/2010
2	Chronic Granulomatous Disease 04/2023 - 06/2011
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2022 - 01/2017
2	Inflammation (Inflammations) 11/2022 - 02/2014
1	Triple Negative Breast Neoplasms 01/2024
1	Fatigue 01/2024
1	Inborn Genetic Diseases (Disease, Hereditary) 04/2023
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2022
1	Melanoma (Melanoma, Malignant) 09/2022
1	Lung Neoplasms (Lung Cancer) 09/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	COVID-19 01/2022
1	Hypoxia (Hypoxemia) 10/2021
1	Hemangioendothelioma 10/2021
1	Alzheimer Disease (Alzheimer's Disease) 03/2021
1	Obesity 03/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2021
1	Diabetes Mellitus 03/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Non-alcoholic Fatty Liver Disease 01/2019
1	B-Cell Lymphoma (Lymphoma, B Cell) 07/2015
1	Xeroderma Pigmentosum (Kaposi's Disease) 11/2012
1	Communicable Diseases (Infectious Diseases) 06/2011
1	Pulmonary Alveolar Proteinosis 03/2011
1	T-Cell Lymphoma (Lymphoma, T Cell) 02/2011

Drug/Important Bio-Agent (IBA)

4	Superoxides (Superoxide)IBA 04/2023 - 03/2011
2	Annexin A2 (Annexin II)IBA 01/2024 - 01/2023
2	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 01/2024 - 01/2023
2	NADPH Oxidases (NAD(P)H oxidase)IBA 04/2023 - 10/2021
2	CollagenIBA 01/2023 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 09/2022 - 10/2021
2	PhytochemicalsIBA 03/2021 - 01/2018
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2018 - 04/2010
1	linaloolIBA 01/2024
1	AntioxidantsIBA 01/2024
1	CytokinesIBA 01/2024
1	Dopamine (Intropin)FDA LinkGeneric 01/2024
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2024
1	InterleukinsIBA 01/2024
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2024
1	Oxygen (Dioxygen)IBA 01/2024
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2024
1	NADPH Oxidase 2IBA 04/2023
1	IntegrinsIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 12/2022
1	Toll-Like Receptor 4IBA 12/2022
1	pyrazoleIBA 11/2022
1	RNA (Ribonucleic Acid)IBA 11/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2022
1	histidine-rich proteinsIBA 09/2022
1	Chemotactic FactorsIBA 09/2022
1	Blood Proteins (Serum Proteins)IBA 09/2022
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2021
1	NADPH Oxidase 4IBA 10/2021
1	Messenger RNA (mRNA)IBA 10/2021
1	CX 5461IBA 11/2020
1	RNA Polymerase I (Polymerase I, RNA)IBA 11/2020
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2019
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2019
1	ResveratrolIBA 01/2018
1	StilbenesIBA 01/2018
1	lysophosphatidic acidIBA 01/2017
1	matrigelIBA 01/2017
1	Protein Isoforms (Isoforms)IBA 07/2015
1	Cytidine DeaminaseIBA 07/2015
1	LipidsIBA 02/2014
1	Peptides (Polypeptides)IBA 02/2014
1	ChemokinesIBA 02/2014
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 11/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2011
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 03/2011
1	Syk KinaseIBA 02/2011
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 02/2011
1	Agammaglobulinaemia Tyrosine KinaseIBA 02/2011
1	PolyphenolsIBA 04/2010
1	CurcuminIBA 04/2010
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 04/2010

Therapy/Procedure

1	Oral Administration 01/2022
1	Drug Therapy (Chemotherapy) 11/2020
1	Therapeutics 04/2010